United States Ketorolac Market Report 2018

January 2018 | 111 pages | ID: U68D7F35E1CEN
QYResearch

Abstracts

In this report, the United States Ketorolac market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Ketorolac in these regions, from 2013 to 2025 (forecast).

United States Ketorolac market competition by top manufacturers/players, with Ketorolac sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Allergan
• DeepCare Health
• Cadila
• FDC
• Intas Laboratories
• Gufic Chem
• Ranbaxy
• Adley Formulation
• Neon Laboratories
• Sun Pharmaceutical Industries
• Cipla
• Dallas Pharmaceuticals
• Nicholas Piramal India
• AHPL

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tables
• Injection
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Medical Uses
• Chemistry Uses
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Ketorolac Market Report 2018

1 KETOROLAC OVERVIEW

1.1 Product Overview and Scope of Ketorolac
1.2 Classification of Ketorolac by Product Category
  1.2.1 United States Ketorolac Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Ketorolac Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Tables
  1.2.4 Injection
  1.2.5 Other
1.3 United States Ketorolac Market by Application/End Users
  1.3.1 United States Ketorolac Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Medical Uses
  1.3.3 Chemistry Uses
  1.3.4 Other
1.4 United States Ketorolac Market by Region
  1.4.1 United States Ketorolac Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Ketorolac Status and Prospect (2013-2025)
  1.4.3 Southwest Ketorolac Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Ketorolac Status and Prospect (2013-2025)
  1.4.5 New England Ketorolac Status and Prospect (2013-2025)
  1.4.6 The South Ketorolac Status and Prospect (2013-2025)
  1.4.7 The Midwest Ketorolac Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Ketorolac (2013-2025)
  1.5.1 United States Ketorolac Sales and Growth Rate (2013-2025)
  1.5.2 United States Ketorolac Revenue and Growth Rate (2013-2025)

2 UNITED STATES KETOROLAC MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Ketorolac Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Ketorolac Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Ketorolac Average Price by Players/Suppliers (2013-2018)
2.4 United States Ketorolac Market Competitive Situation and Trends
  2.4.1 United States Ketorolac Market Concentration Rate
  2.4.2 United States Ketorolac Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Ketorolac Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES KETOROLAC SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Ketorolac Sales and Market Share by Region (2013-2018)
3.2 United States Ketorolac Revenue and Market Share by Region (2013-2018)
3.3 United States Ketorolac Price by Region (2013-2018)

4 UNITED STATES KETOROLAC SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Ketorolac Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Ketorolac Revenue and Market Share by Type (2013-2018)
4.3 United States Ketorolac Price by Type (2013-2018)
4.4 United States Ketorolac Sales Growth Rate by Type (2013-2018)

5 UNITED STATES KETOROLAC SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Ketorolac Sales and Market Share by Application (2013-2018)
5.2 United States Ketorolac Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES KETOROLAC PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Allergan
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ketorolac Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Allergan Ketorolac Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 DeepCare Health
  6.2.2 Ketorolac Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 DeepCare Health Ketorolac Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Cadila
  6.3.2 Ketorolac Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cadila Ketorolac Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 FDC
  6.4.2 Ketorolac Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 FDC Ketorolac Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Intas Laboratories
  6.5.2 Ketorolac Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Intas Laboratories Ketorolac Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Gufic Chem
  6.6.2 Ketorolac Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Gufic Chem Ketorolac Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Ranbaxy
  6.7.2 Ketorolac Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Ranbaxy Ketorolac Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Adley Formulation
  6.8.2 Ketorolac Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Adley Formulation Ketorolac Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Neon Laboratories
  6.9.2 Ketorolac Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Neon Laboratories Ketorolac Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Sun Pharmaceutical Industries
  6.10.2 Ketorolac Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Sun Pharmaceutical Industries Ketorolac Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Cipla
6.12 Dallas Pharmaceuticals
6.13 Nicholas Piramal India
6.14 AHPL

7 KETOROLAC MANUFACTURING COST ANALYSIS

7.1 Ketorolac Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ketorolac

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ketorolac Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ketorolac Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES KETOROLAC MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Ketorolac Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Ketorolac Sales Volume Forecast by Type (2018-2025)
11.3 United States Ketorolac Sales Volume Forecast by Application (2018-2025)
11.4 United States Ketorolac Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Ketorolac
Figure United States Ketorolac Market Size (K MT) by Type (2013-2025)
Figure United States Ketorolac Sales Volume Market Share by Type (Product Category) in 2017
Figure Tables Product Picture
Figure Injection Product Picture
Figure Other Product Picture
Figure United States Ketorolac Market Size (K MT) by Application (2013-2025)
Figure United States Sales Market Share of Ketorolac by Application in 2017
Figure Medical Uses Examples
Table Key Downstream Customer in Medical Uses
Figure Chemistry Uses Examples
Table Key Downstream Customer in Chemistry Uses
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Ketorolac Market Size (Million USD) by Region (2013-2025)
Figure The West Ketorolac Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Ketorolac Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Ketorolac Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Ketorolac Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Ketorolac Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Ketorolac Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Ketorolac Sales (K MT) and Growth Rate (2013-2025)
Figure United States Ketorolac Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Ketorolac Market Major Players Product Sales Volume (K MT) (2013-2018)
Table United States Ketorolac Sales (K MT) of Key Players/Suppliers (2013-2018)
Table United States Ketorolac Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Ketorolac Sales Share by Players/Suppliers
Figure 2017 United States Ketorolac Sales Share by Players/Suppliers
Figure United States Ketorolac Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Ketorolac Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Ketorolac Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Ketorolac Revenue Share by Players/Suppliers
Figure 2017 United States Ketorolac Revenue Share by Players/Suppliers
Table United States Market Ketorolac Average Price (USD/MT) of Key Players/Suppliers (2013-2018)
Figure United States Market Ketorolac Average Price (USD/MT) of Key Players/Suppliers in 2017
Figure United States Ketorolac Market Share of Top 3 Players/Suppliers
Figure United States Ketorolac Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Ketorolac Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Ketorolac Product Category
Table United States Ketorolac Sales (K MT) by Region (2013-2018)
Table United States Ketorolac Sales Share by Region (2013-2018)
Figure United States Ketorolac Sales Share by Region (2013-2018)
Figure United States Ketorolac Sales Market Share by Region in 2017
Table United States Ketorolac Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Ketorolac Revenue Share by Region (2013-2018)
Figure United States Ketorolac Revenue Market Share by Region (2013-2018)
Figure United States Ketorolac Revenue Market Share by Region in 2017
Table United States Ketorolac Price (USD/MT) by Region (2013-2018)
Table United States Ketorolac Sales (K MT) by Type (2013-2018)
Table United States Ketorolac Sales Share by Type (2013-2018)
Figure United States Ketorolac Sales Share by Type (2013-2018)
Figure United States Ketorolac Sales Market Share by Type in 2017
Table United States Ketorolac Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Ketorolac Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Ketorolac by Type (2013-2018)
Figure Revenue Market Share of Ketorolac by Type in 2017
Table United States Ketorolac Price (USD/MT) by Types (2013-2018)
Figure United States Ketorolac Sales Growth Rate by Type (2013-2018)
Table United States Ketorolac Sales (K MT) by Application (2013-2018)
Table United States Ketorolac Sales Market Share by Application (2013-2018)
Figure United States Ketorolac Sales Market Share by Application (2013-2018)
Figure United States Ketorolac Sales Market Share by Application in 2017
Table United States Ketorolac Sales Growth Rate by Application (2013-2018)
Figure United States Ketorolac Sales Growth Rate by Application (2013-2018)
Table Allergan Basic Information List
Table Allergan Ketorolac Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Allergan Ketorolac Sales Growth Rate (2013-2018)
Figure Allergan Ketorolac Sales Market Share in United States (2013-2018)
Figure Allergan Ketorolac Revenue Market Share in United States (2013-2018)
Table DeepCare Health Basic Information List
Table DeepCare Health Ketorolac Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure DeepCare Health Ketorolac Sales Growth Rate (2013-2018)
Figure DeepCare Health Ketorolac Sales Market Share in United States (2013-2018)
Figure DeepCare Health Ketorolac Revenue Market Share in United States (2013-2018)
Table Cadila Basic Information List
Table Cadila Ketorolac Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Cadila Ketorolac Sales Growth Rate (2013-2018)
Figure Cadila Ketorolac Sales Market Share in United States (2013-2018)
Figure Cadila Ketorolac Revenue Market Share in United States (2013-2018)
Table FDC Basic Information List
Table FDC Ketorolac Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure FDC Ketorolac Sales Growth Rate (2013-2018)
Figure FDC Ketorolac Sales Market Share in United States (2013-2018)
Figure FDC Ketorolac Revenue Market Share in United States (2013-2018)
Table Intas Laboratories Basic Information List
Table Intas Laboratories Ketorolac Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Intas Laboratories Ketorolac Sales Growth Rate (2013-2018)
Figure Intas Laboratories Ketorolac Sales Market Share in United States (2013-2018)
Figure Intas Laboratories Ketorolac Revenue Market Share in United States (2013-2018)
Table Gufic Chem Basic Information List
Table Gufic Chem Ketorolac Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Gufic Chem Ketorolac Sales Growth Rate (2013-2018)
Figure Gufic Chem Ketorolac Sales Market Share in United States (2013-2018)
Figure Gufic Chem Ketorolac Revenue Market Share in United States (2013-2018)
Table Ranbaxy Basic Information List
Table Ranbaxy Ketorolac Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Ranbaxy Ketorolac Sales Growth Rate (2013-2018)
Figure Ranbaxy Ketorolac Sales Market Share in United States (2013-2018)
Figure Ranbaxy Ketorolac Revenue Market Share in United States (2013-2018)
Table Adley Formulation Basic Information List
Table Adley Formulation Ketorolac Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Adley Formulation Ketorolac Sales Growth Rate (2013-2018)
Figure Adley Formulation Ketorolac Sales Market Share in United States (2013-2018)
Figure Adley Formulation Ketorolac Revenue Market Share in United States (2013-2018)
Table Neon Laboratories Basic Information List
Table Neon Laboratories Ketorolac Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Neon Laboratories Ketorolac Sales Growth Rate (2013-2018)
Figure Neon Laboratories Ketorolac Sales Market Share in United States (2013-2018)
Figure Neon Laboratories Ketorolac Revenue Market Share in United States (2013-2018)
Table Sun Pharmaceutical Industries Basic Information List
Table Sun Pharmaceutical Industries Ketorolac Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sun Pharmaceutical Industries Ketorolac Sales Growth Rate (2013-2018)
Figure Sun Pharmaceutical Industries Ketorolac Sales Market Share in United States (2013-2018)
Figure Sun Pharmaceutical Industries Ketorolac Revenue Market Share in United States (2013-2018)
Table Cipla Basic Information List
Table Dallas Pharmaceuticals Basic Information List
Table Nicholas Piramal India Basic Information List
Table AHPL Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ketorolac
Figure Manufacturing Process Analysis of Ketorolac
Figure Ketorolac Industrial Chain Analysis
Table Raw Materials Sources of Ketorolac Major Players/Suppliers in 2017
Table Major Buyers of Ketorolac
Table Distributors/Traders List
Figure United States Ketorolac Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure United States Ketorolac Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Ketorolac Price (USD/MT) Trend Forecast (2018-2025)
Table United States Ketorolac Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Ketorolac Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Ketorolac Sales Volume (K MT) Forecast by Type in 2025
Table United States Ketorolac Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Ketorolac Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Ketorolac Sales Volume (K MT) Forecast by Application in 2025
Table United States Ketorolac Sales Volume (K MT) Forecast by Region (2018-2025)
Table United States Ketorolac Sales Volume Share Forecast by Region (2018-2025)
Figure United States Ketorolac Sales Volume Share Forecast by Region (2018-2025)
Figure United States Ketorolac Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources